The Globe and Mail reports in its Tuesday, Nov. 11, edition that Raymond James analyst Stephen Boland has reiterated his "outperform" recommendation for Fairfax Financial Holdings. The Globe's David Leeder writes that Mr. Boland cut his share target by $150 to $2,900. Analysts on average target the shares at $2,880.16. Mr. Boland says in a note: "With the shares experiencing their most meaningful pullback for some time -- we suspect on fears of a softening insurance market -- Fairfax continues to execute across all facets of the business. The equity portfolio continues to perform strongly, the fixed income portfolio remains conservatively positioned with optionality on spread capture, while the increasing diversity of the insurance operations has left Fairfax considerably less exposed to a softer North American P&C cycle." The Globe reported on Aug. 6 that RBC Capital analyst Bart Dziarski had reaffirmed his "outperform" recommendation for Fairfax Financial. It was then worth $2,391.21. The Globe reported on Oct. 17 that Mr. Boland had reaffirmed his "outperform" recommendation for Fairfax Financial. In the item he gave his share target a $150 boost to $3,050. The shares could then be had for $2,327.34.